{"schema_version":"secwatch.filing_event.v1","accession":"0001731122-22-000164","form_type":"8-K","ticker":"AVXL","cik":"0001314052","company_name":"ANAVEX LIFE SCIENCES CORP.","filed_at":"2022-02-04T23:59:59+00:00","discovered_at":"2026-05-14T18:04:05.873250+00:00","generated_at":"2026-06-27T10:58:58.487919+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Anavex clarifies AVATAR Phase 3 trial endpoints; plans FDA meeting for Rett syndrome approval","bullets":["Anavex clarifies that the January 2022 clinicaltrials.gov update was not real-time and does not reflect late endpoint/phase changes.","AVATAR Phase 3 endpoints were updated per ICH guidelines and approved by UK MHRA and Australian HREC before the study.","Based on AVATAR Phase 3 and prior Phase 2 success, Anavex plans to meet with FDA to discuss approval pathway for blarcamesine in Rett.","No FDA-approved drugs for Rett syndrome; blarcamesine has Fast Track, Rare Pediatric Disease, and Orphan Drug designations."],"urls":{"canonical":"https://secwatch.observer/filing/0001731122-22-000164","json":"https://secwatch.observer/filing/0001731122-22-000164.json","markdown":"https://secwatch.observer/filing/0001731122-22-000164.md","text":"https://secwatch.observer/filing/0001731122-22-000164.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1314052/000173112222000164/0001731122-22-000164-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1314052/000173112222000164/e3471_8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T10:58:58.487919+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}